Clinical Trial Update: Safety Study of MucoCept-CVN [Phase 1]

View source ↗

Summary

A Phase 1 safety study of MucoCept-CVN for HIV-1 infection is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• MucoCept-CVN

Snippet

Sponsor: Craig Cohen, MD, MPH | Conditions: HIV -1 Infection | Phase 1 | Status: RECRUITING